source,source_name,source_type,relation,target,target_name,target_type,mechanism,evidence
DB16845,Aducanumab,drug,targets,P05067,Amyloid-beta precursor protein (APP) (ABPP) (APPI) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31],protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,P05067,Amyloid-beta precursor protein (APP) (ABPP) (APPI) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31],protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,P29216,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,P29216,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,Q28757,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) [Cleaved into: Soluble APP-beta (S-APP-beta); CTF-alpha; Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); Gamma-secretase C-terminal fragment 59 (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Gamma-CTF(57))],protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,Q28757,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) [Cleaved into: Soluble APP-beta (S-APP-beta); CTF-alpha; Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); Gamma-secretase C-terminal fragment 59 (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Gamma-CTF(57))],protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,Q28748,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) [Cleaved into: Soluble APP-beta (S-APP-beta); CTF-alpha; Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); Gamma-secretase C-terminal fragment 59 (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Gamma-CTF(57))],protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,Q28748,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) [Cleaved into: Soluble APP-beta (S-APP-beta); CTF-alpha; Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); Gamma-secretase C-terminal fragment 59 (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Gamma-CTF(57))],protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,Q28280,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) [Cleaved into: Soluble APP-beta (S-APP-beta); CTF-alpha; Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); Gamma-secretase C-terminal fragment 59 (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Gamma-CTF(57))],protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,Q28280,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) [Cleaved into: Soluble APP-beta (S-APP-beta); CTF-alpha; Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); Gamma-secretase C-terminal fragment 59 (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Gamma-CTF(57))],protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,Q29149,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) [Cleaved into: Soluble APP-beta (S-APP-beta); CTF-alpha; Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); Gamma-secretase C-terminal fragment 59 (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Gamma-CTF(57))],protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,Q29149,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) [Cleaved into: Soluble APP-beta (S-APP-beta); CTF-alpha; Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); Gamma-secretase C-terminal fragment 59 (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Gamma-CTF(57))],protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2K6MR28,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2K6MR28,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2K5NRB5,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2K5NRB5,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2R8ZBT8,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2R8ZBT8,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A805PQK8,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A805PQK8,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2K6QWN7,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2K6QWN7,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2K6QWQ3,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2K6QWQ3,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8D2GBR7,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8D2GBR7,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2K6ECF1,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2K6ECF1,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2K5ZUC0,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2K5ZUC0,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C9HQQ0,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C9HQQ0,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2I3MY59,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2I3MY59,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2K5ZU33,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2K5ZU33,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2K5ZUH7,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2K5ZUH7,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2K6MR25,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2K6MR25,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2I2ZS14,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2I2ZS14,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2I3TXS0,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2I3TXS0,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A0A0MRG2,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A0A0MRG2,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,P53601,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Gamma-CTF(50)); C31],protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,P53601,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Gamma-CTF(50)); C31],protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,Q95241,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Gamma-CTF(50)); C31],protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,Q95241,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Gamma-CTF(50)); C31],protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,P79307,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Gamma-CTF(50)); C31],protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,P79307,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Gamma-CTF(50)); C31],protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,Q5IS80,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Gamma-CTF(50)); C31],protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,Q5IS80,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Gamma-CTF(50)); C31],protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2K5ZU56,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2K5ZU56,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2I3LFQ6,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2I3LFQ6,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2I3SP96,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2I3SP96,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2I3GV49,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2I3GV49,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2I3G872,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2I3G872,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2K6FBJ3,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2K6FBJ3,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,F7ELT1,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,F7ELT1,Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein),protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,P86906,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) [Cleaved into: Amyloid-beta protein 40 (Abeta40) (Beta-APP40)],protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,P86906,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) [Cleaved into: Amyloid-beta protein 40 (Abeta40) (Beta-APP40)],protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,Q60495,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF) (CTF-beta); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF) (CTF-alpha); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31],protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,Q60495,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF) (CTF-beta); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF) (CTF-alpha); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31],protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,Q28053,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) [Cleaved into: Soluble APP-beta (S-APP-beta); CTF-alpha; Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); Gamma-secretase C-terminal fragment 59 (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Gamma-CTF(57))],protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,Q28053,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) [Cleaved into: Soluble APP-beta (S-APP-beta); CTF-alpha; Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); Gamma-secretase C-terminal fragment 59 (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Gamma-CTF(57))],protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A218KGR2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A218KGR2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,E9PG40,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,E9PG40,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,O97917,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,O97917,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A3S5ZPG2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A3S5ZPG2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,Q08E54,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,Q08E54,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A3Q1MI56,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A3Q1MI56,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A3Q1MGE4,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A3Q1MGE4,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A3Q1MLQ6,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A3Q1MLQ6,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A3Q1LUG2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A3Q1LUG2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8B7A2T7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8B7A2T7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8B7SZC0,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8B7SZC0,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C0QPE3,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C0QPE3,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2K5CBE8,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2K5CBE8,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A452QNF7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A452QNF7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A7M4F553,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A7M4F553,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A803YAC4,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A803YAC4,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8B7A6C0,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8B7A6C0,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C3TMU8,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C3TMU8,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C6Y1J4,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C6Y1J4,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8D0QCY0,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8D0QCY0,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8D2D2Q1,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8D2D2Q1,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0AA97J155,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0AA97J155,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0AA97KRH3,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0AA97KRH3,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A340Y268,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A340Y268,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A3Q0DMH8,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A3Q0DMH8,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A4W2F103,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A4W2F103,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A5F5PLP1,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A5F5PLP1,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A7N4V495,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A7N4V495,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A7N5JN45,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A7N5JN45,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8B7A175,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8B7A175,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C0TD40,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C0TD40,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C4JTW1,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C4JTW1,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C4XWX9,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C4XWX9,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C5MID8,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C5MID8,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C5MIW7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C5MIW7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C5MQM6,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C5MQM6,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C6XYI2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C6XYI2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8I3S2G8,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8I3S2G8,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,F6ZXB5,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,F6ZXB5,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A1U7S667,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A1U7S667,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A1U7SPE0,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A1U7SPE0,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2K5U6Q9,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2K5U6Q9,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A340Y4F1,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A340Y4F1,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A452UH39,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A452UH39,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A4X1UDV2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A4X1UDV2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A663N844,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A663N844,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A673U602,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A673U602,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A673UH66,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A673UH66,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C4JTX2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C4JTX2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C8Z2M0,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C8Z2M0,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C9JHE8,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C9JHE8,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8D0VXI1,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8D0VXI1,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8D2H0B1,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8D2H0B1,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8I3P2Q2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8I3P2Q2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8I3S2H9,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8I3S2H9,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A9B0WZ92,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A9B0WZ92,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A1U7SD12,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A1U7SD12,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A1U7SVE5,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A1U7SVE5,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A384CYW7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A384CYW7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A4W2DEQ7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A4W2DEQ7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A4X1UF49,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A4X1UF49,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A6I9XER8,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A6I9XER8,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A6J3CKW6,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A6J3CKW6,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C0TG24,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C0TG24,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C0VAQ8,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C0VAQ8,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C3TMN7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C3TMN7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C5MLZ7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C5MLZ7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C5XIY7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C5XIY7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C7A1L6,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C7A1L6,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8D2QJP4,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8D2QJP4,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A9B0WYF1,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A9B0WYF1,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A9B0WZ27,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A9B0WZ27,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,U3IMZ0,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,U3IMZ0,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A1U7SRY3,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A1U7SRY3,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2U3WVA0,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2U3WVA0,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2U3WVC0,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2U3WVC0,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A340XYV5,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A340XYV5,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A4X2KGG8,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A4X2KGG8,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A674GVP4,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A674GVP4,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A6I9HN60,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A6I9HN60,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A6P5L407,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A6P5L407,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A7N5KHQ6,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A7N5KHQ6,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8B7A167,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8B7A167,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C0TGH9,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C0TGH9,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C5MM05,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C5MM05,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C5SU09,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C5SU09,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C5ZWT2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C5ZWT2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C6XYL3,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C6XYL3,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C6Y1W3,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C6Y1W3,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8D2GPT3,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8D2GPT3,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8V0YAY1,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8V0YAY1,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,H2ZW72,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,H2ZW72,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A1S3W6U9,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A1S3W6U9,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A1S3W8A7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A1S3W8A7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2I2YBB2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2I2YBB2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2I3SHN1,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2I3SHN1,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2K5CBF7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2K5CBF7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2K5CBM1,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2K5CBM1,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2K6ECF4,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2K6ECF4,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2K6MR17,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2K6MR17,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2R8ZFN4,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2R8ZFN4,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A3Q7T905,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A3Q7T905,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A663EGR5,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A663EGR5,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A663NA02,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A663NA02,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A667I2K9,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A667I2K9,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A670HX11,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A670HX11,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A670HX99,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A670HX99,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A673Y5J5,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A673Y5J5,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A674EMN2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A674EMN2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A6J0B0F3,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A6J0B0F3,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A6J1XYC6,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A6J1XYC6,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A6J3HSB6,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A6J3HSB6,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A6J3RBA4,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A6J3RBA4,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A6P6CD23,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A6P6CD23,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A7M4F3Z4,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A7M4F3Z4,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8B9VZQ1,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8B9VZQ1,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8B9W0J7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8B9W0J7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C0LRE1,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C0LRE1,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C0NNJ0,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C0NNJ0,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C3D2W3,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C3D2W3,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C3D580,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C3D580,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C3TLH2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C3TLH2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C4VHQ0,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C4VHQ0,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C5ZSW5,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C5ZSW5,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C6AV90,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C6AV90,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C7A867,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C7A867,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C9WM85,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C9WM85,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8D0QAL5,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8D0QAL5,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A9V1GIW9,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A9V1GIW9,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0AA97KSB2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0AA97KSB2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,F7BG93,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,F7BG93,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,H0UW66,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,H0UW66,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2I3MME2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2I3MME2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2I3N8B6,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2I3N8B6,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2K5CBD2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2K5CBD2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2K6U8W0,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2K6U8W0,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2K6U949,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2K6U949,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2R8ZIN4,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2R8ZIN4,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A341AF95,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A341AF95,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A452G865,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A452G865,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A493U2L9,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A493U2L9,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A670HYS6,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A670HYS6,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A673U6A5,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A673U6A5,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A6I9IP66,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A6I9IP66,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A6J0GN91,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A6J0GN91,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A6P3HDV8,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A6P3HDV8,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A803VGJ2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A803VGJ2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8B7GBX9,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8B7GBX9,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8B8SRP3,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8B8SRP3,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8B9VYT7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8B9VYT7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C0P301,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C0P301,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C0V7H4,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C0V7H4,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C0V976,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C0V976,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C2Y6V7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C2Y6V7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C2YP37,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C2YP37,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C4JUB0,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C4JUB0,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8C7A4F2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8C7A4F2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8D0UYR5,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8D0UYR5,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8D2KAK9,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8D2KAK9,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8D2NFC7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8D2NFC7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A8D2QJ47,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A8D2QJ47,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A9F2QYF6,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A9F2QYF6,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A9L0KAH7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A9L0KAH7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,I0FGN2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,I0FGN2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2I3MTM7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2I3MTM7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2K5R4G1,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2K5R4G1,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2K5U6L3,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2K5U6L3,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2U3WV95,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2U3WV95,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A2U3WVK4,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A2U3WVK4,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A340XZM2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A340XZM2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A340Y4Z9,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A340Y4Z9,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A3Q7PDW2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A3Q7PDW2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A3Q7S984,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A3Q7S984,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A452G7Y7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A452G7Y7,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A4W2II83,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A4W2II83,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A4X1UF94,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A4X1UF94,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A5F5PX07,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A5F5PX07,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A5F9DQE8,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A5F9DQE8,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A663N838,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A663N838,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A667HAK0,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A667HAK0,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A669QZJ6,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A669QZJ6,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A669QZJ9,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A669QZJ9,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A673U5M9,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A673U5M9,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A674GBF3,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A674GBF3,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB16845,Aducanumab,drug,targets,A0A6J0XFG2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
DB17148,Lecanemab,drug,targets,A0A6J0XFG2,Amyloid-beta A4 protein,protein,Amyloid beta binding,DrugBank
